Cargando…
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
Reports of cardiac adverse events from oncology clinical trials often are at variance with reports derived from clinical observations or data-base reviews. These differences may lead to confusion, as different levels of risks abound in the literature, and the true cardiac risk of using some agents i...
Autores principales: | Ewer, Michael S., Herson, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295280/ https://www.ncbi.nlm.nih.gov/pubmed/35854393 http://dx.doi.org/10.1186/s40959-022-00139-w |
Ejemplares similares
-
Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020) -
Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data
por: Lewis, Tamorah, et al.
Publicado: (2021) -
Incidence of adverse cardiovascular events in patients with insomnia: A systematic review and meta-analysis of real-world data
por: Ali, Eman, et al.
Publicado: (2023) -
An Appreciation of Anatomy in the Molecular World
por: Jensen, Bjarke, et al.
Publicado: (2020) -
Clinical trial preparations for the next pandemic
por: Herson, Jay
Publicado: (2021)